IPS legal adviser José Luis Urizar admitted that of the 60% lack of medicine, since 2021 it has reached 90% of drugs and supplies in stock. He added that the 10% that is missing is due to a question of suppliers and of these with their suppliers of origin and even due to external difficulties in the tenders.
Nevertheless, recognized that there is an accumulated historical debt of 240 million dollars, that comes from past decades.
“With what the current administration, we are focused on advancing the bidding processes and today there is 90% with a valid contract and 10% in the award process,” he assured.
About, Urizar said that there are difficulties, despite having a valid contract. He added that there are also often difficulties in bidding processes due to external problems. “We have already approached the Public Procurement Directorate to seek alternative mechanisms to mitigate such situations,” he stressed.
He insisted on the search for options, saying afterwards that the Law is rigid with the social security. He expressed his confidence that other avenues of solution could be found in the future.
Related note: IPS requests credit to cover debt of USD 240 million with suppliers
He pointed out that there is planning, but reiterated that the obstacles, sometimes, occur in the bidding process, even in the external discussion about the bases and conditions between the same providers and that is lengthy and takes time.
He argued that there is an Exception Law. However, even so, that still takes 30-40 days. “The patient is right, he cannot wait. There is an effort and that can be seen in the improvement since last year”. he emphasized her.
On the other hand, denied that retirement funds can be used to save the financial situation. “In no meeting I participated in was there any talk of using retirement funds. In addition, that is prohibited by the IPS charter”, she clarified.
Urizar hopes that there is a national understanding to avoid possible legal actions in the face of the debt that has been going on for years and today is for 240 million dollars. “We must look for mechanisms to continue complying with the obligations,” he stressed. He stressed that the entire administration has internal and external auditors.
The entrance Policyholders denounce shortages, but IPS says they have 90% of drugs and supplies in stock was first published in diary TODAY.
